期刊文献+

消癌平注射液对乳腺癌患者术后免疫功能的影响 被引量:4

Effects of XiaoaipingInjection on the Immune Function in Patients with Breast Cancer After Operation
原文传递
导出
摘要 目的:探讨消癌平注射液对乳腺癌患者术后免疫功能的影响。方法:选取2013年6月至2015年7月84例术后乳腺癌患者,随机分为对照组(n=42)及观察组(n=42)。两组在术后同时行CMF[环磷酰胺(CTX)+甲氨蝶呤(MTX)+氟尿嘧啶(5-FU)]化疗方案。对照组仅行化疗治疗,观察组在对照基础上静脉滴注消癌平注射液。对比分析两组患者的治疗效果、术后免疫功能、炎症因子及血管内皮生长因子(VEGF)水平的变化。结果:观察组患者治疗后Th17细胞比率低于对照组,而Th17/Treg、CD4^+CD25^+Treg细胞的比率则高于对照组(P<0.05)。观察组患者术后白细胞介素(IL)-1,6、肿瘤细胞坏死因子-α(TNF-α)及VEGF水平显著低于对照组(P<0.05)。结论:消癌平注射液能有效改善乳腺癌化疗患者的免疫功能,降低化疗对患者的毒副作用,提高治疗效果。 Objective:To investigate the effects of Xiaoaipinginjection,a traditional Chinese medicine,on the immune function in patients with breast cancers after operation.Methods:84cases of breast cancer undergoing chemotherapy after operation were randomly divided into control group(n=42)and observation group(n=42)from June 2013 to July 2015.All the patients in the control group were treated with CMF,cyclophosphamide(CTX)+ methotrexate(MTX)+ fluorouracil(5-FU),and those in the observation group were treated with Xiaoaipinginjection+ CMF.The levels of postoperative immune function,inflammatory factors and VEGF of the two groups were compared.Results:The levels of Th17 of the observation group were lower than those of the control group,whereas the levels of Th17/Treg and the levels of CD4~+CD~+ 25Treg cells of the observation group were higher than those of the control group(P〈0.05).Moreover,the levels of interleukin-1,-6,tumor necrosis factor-α(TNF-α)and VEGF of the observation group were obviously lower than those of the control group(P〈0.05).Conclusion:Xiaoaipinginjection can effectively improve the immune function in breast cancer patients with chemotherapy,reduce side effects,and improve therapeutic effect.
出处 《武汉大学学报(医学版)》 CAS 2016年第5期782-785,共4页 Medical Journal of Wuhan University
关键词 消癌平注射液 乳腺癌 免疫功能 炎症因子 血管内皮生长因子 Xiaoaiping Injection Breast Cancer Immune Function Inflammatory Factor Vascular Endothelial Growth Factor
  • 相关文献

参考文献6

二级参考文献38

  • 1黄红艳,江泽飞,王涛,张少华,边莉,曹阳,吴世凯,宋三泰.贝伐珠单抗联合多西他赛治疗Her-2阴性复发转移性乳腺癌的疗效观察[J].中国癌症杂志,2011,21(3):220-224. 被引量:18
  • 2袁秀英,范忠泽,黄秀英.消癌平注射液治疗14例晚期胃癌的临床观察[J].上海医药,1996(6):12-13. 被引量:27
  • 3姜成,郑全英,肖何.消癌平抗肿瘤药理实验与临床研究进展[J].上海中医药杂志,2007,41(7):78-79. 被引量:24
  • 4DENKERT C, LOIBL S, NOSKE A, et al. Tmnor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer [ J ] . J Clin Oncol, 2010, 28(1): 105-113.
  • 5YAMAGUCHI R, TANAKA M, YANO A, et al. Tumor- infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer [ J ] . Hum Pathol, 2012, 43(10): 1688-1694.
  • 6BLAKE-MORTINMER J S, SEPHTON S E, CARLSON R W, et al. Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer [ J ] . Breast J, 2004, 10(3): 195-199.
  • 7LIU S, LACHAPELLE J, I.EUNG S, et al. CD8+lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer [ J ] . Breast Cancer Res, 2012, 14(2): R48.
  • 8WIJAYAHADI N, HARON M R, STANSLAS J, et al. Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens [ J ] . J Chemother, 2007, 19(6): 716-723.
  • 9MELICHAR B, TOUSKOVA M, DVORAK J, et al. The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy [ J ] . hnmunopharmacol Immunotoxicol, 2001, 23(2): 163-173.
  • 10KOTSAKIS A, SARRA E, PERAKI M, et al. Docetaxel- induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis [ J ] . Cancer, 2000, 89(6): 1380-1386.

共引文献54

同被引文献35

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部